Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 14, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
03:59

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

Resympathicotomy.

Peter B Licht1, Anders Clausen, Lars Ladegaard

  • 1Department of Cardiothoracic Surgery, Odense University Hospital, Odense, Denmark. peter.licht@ouh.regionsyddanmark.dk

The Annals of Thoracic Surgery
|March 27, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials.

Lancet (London, England)·2026
Same author

From tradition to transformation: evolving paradigms in surgical lung cancer treatment.

Translational lung cancer research·2025
Same author

Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease.

Journal of Parkinson's disease·2025
Same author

Immunological effects of post-operative epidural analgesia versus oral opioids in VATS.

Danish medical journal·2024
Same author

Solid and semi-solid perspectives in thoracic surgery.

The Lancet. Respiratory medicine·2024
Same author

Sympathicotomy for isolated facial blushing: long-term follow-up of a randomized trial.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2023
Same journal

Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention for Stable Multivessel Coronary Disease in the Current Era.

The Annals of thoracic surgery·2026
Same journal

Should the DeBakey Classification Be Reconsidered for Acute Type A Aortic Dissection?

The Annals of thoracic surgery·2026
Same journal

A Health Tracking Application Leads to An Avid Cyclist Being Diagnosed with ALCAPA at 52 years old, Warranting a Takeuchi Repair.

The Annals of thoracic surgery·2026
Same journal

Impact of preoperative and postoperative modern guideline-directed medical therapy on survival following coronary artery bypass grafting.

The Annals of thoracic surgery·2026
Same journal

Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?

The Annals of thoracic surgery·2026
Same journal

Lymph Node Dissection and Chylothorax - Balancing Oncologic Benefit Against Morbidity.

The Annals of thoracic surgery·2026
See all related articles

Resympathicotomy (re-ETS) effectively treats primary hyperhidrosis and facial blushing when initial surgery fails. However, patients should be informed that compensatory sweating may worsen, particularly after re-ETS for primary technical failure.

Area of Science:

  • Medical Science
  • Surgical Procedures
  • Patient Outcomes

Background:

  • Endoscopic thoracic sympathicotomy (ETS) treats hyperhidrosis and blushing but can fail or recur.
  • Resympathicotomy (re-ETS) is a controversial treatment for ETS failure.
  • The impact of re-ETS on compensatory sweating is not well-documented.

Purpose of the Study:

  • To evaluate the effectiveness of re-ETS for primary hyperhidrosis and facial blushing.
  • To assess the influence of re-ETS on compensatory sweating.
  • To analyze outcomes based on reasons for re-ETS (primary failure vs. recurrence).

Main Methods:

  • A 10-year follow-up study (1997-2007) of patients undergoing re-ETS.
  • Consecutive patients received questionnaires regarding treatment effects and side effects.

More Related Videos

Surgical Lumbar Sympathectomy in Mice
05:24

Surgical Lumbar Sympathectomy in Mice

Published on: July 5, 2024

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
03:59

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

Surgical Lumbar Sympathectomy in Mice
05:24

Surgical Lumbar Sympathectomy in Mice

Published on: July 5, 2024

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

  • Analysis of outcomes based on unilateral/bilateral primary failure or symptom recurrence.

    • Main Results:

    • 48 patients underwent re-ETS for primary or recurrent symptoms.
    • Symptom improvement after re-ETS was 96% for unilateral primary failure, 50% for bilateral, and 75% for recurrence.
    • Compensatory sweating worsened in 38% after re-ETS, especially for primary failure.

    Conclusions:

    • Primary technical failure after ETS is common.
    • Re-ETS is an effective treatment for primary failure and recurrent symptoms.
    • Patients must be counseled about potential worsening of compensatory sweating after re-ETS, particularly in cases of unilateral technical failure.